Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Halozyme Announces Plans For CFO Transition, Names CFO

SAN DIEGO, June 5, 2015 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO), an oncology biotech company, today announced its chief financial officer David Ramsay will retire this summer, and named biotech veteran Laurie Stelzer as his successor. Stelzer will assume CFO duties on June 15 and will work with Ramsay through a transition period. “Since last […]

Read More »

Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development

Former chief scientific officer for Shire Pharmaceuticals and Relmada Therapeutics also headed R&D for Adolor and Stem Cells, Inc.; a trained psychiatrist and CNS specialist, Dr. Salinas arrives as Turing readies clinical trial programs NEW YORK (June 1, 2015) – Turing Pharmaceuticals AG announced that life sciences executive and medical researcher Eliseo Oreste Salinas, MD, MSc,  […]

Read More »

BriaCell Therapeutics Announces New President, CEO and Chairman of the Board

VANCOUVER, BC–(Marketwired – June 01, 2015) – BriaCell Therapeutics Corp (TSX VENTURE: BCT) (“BriaCell“, the “Company”, or “BCT“) is pleased to announce that it has appointed Joseph Wagner, PhD as President and CEO of the Company, effective today. Dr. Wagner comes to BriaCell following his resignation as President and CEO of OncoCyte Corporation, a subsidiary […]

Read More »

Ivor Macleod Appointed Senior Vice President, Chief Financial Officer and Chief Compliance Officer of Eisai Inc.

WOODCLIFF LAKE, N.J., June 1, 2015 /PRNewswire/ — Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announces the immediate appointment of Ivor Macleod to the position of Senior Vice President, Chief Financial Officer (CFO) and Chief Compliance Officer. In this role, Mr. Macleod will have full oversight and responsibility for leading Eisai’s […]

Read More »

Publicis Touchpoint Solutions Announces New Executive Appointment

Mohan Ganesan Joins the Organization as Chief Financial Officer Yardley, PA—June 1, 2015—Publicis Touchpoint Solutions, Inc—a leading provider of customized, omnichannel healthcare sales, service, and clinical teams—announced today that Mohan Ganesan has joined the organization as chief financial officer (CFO). Ganesan assumes responsibility for all of Touchpoint’s financial operations and will join the executive leadership […]

Read More »

Bristol-Myers sues immunotherapy exec who left for AstraZeneca

Bristol-Myers Squibb has sued a top cancer immunotherapy executive for violating confidentiality and non-compete agreements after he left for direct competitor AstraZeneca, court documents show The suit, filed in Delaware’s Court of Chancery late on Thursday, said that David Berman violated agreements that prevented him from using confidential and trade secret information when he accepted […]

Read More »

Gilead Will Hire Up to 170 Scientists in $100 Million Edmonton Expansion

Gilead Alberta ULC, a subsidiary of Gilead Sciences, Inc. (GILD), had a ribbon-cutting ceremony yesterday for the first of two new lab buildings at its Edmonton, Alberta (Canada) site. In addition, the company announced it will invest $100 million in expansion and upgrades. Gilead did not respond to request for an interview in time for […]

Read More »

What You May Have Missed in Biotech: Eye Drug Fails, Ear Drug Flops, and Herpes Drug Succeeds

Biotech was full of news this week on clinical trials for the eyes, the ears, and other body parts people don’t usually talk about. Catch up on your headlines here: Eleven Biotherapeutics Fails in Dry Eye Clinical Trial Cambridge, Mass.-based Eleven Biotherapeutics lost 75% of its value, ending the week at $3 a share, after […]

Read More »

Merus Labs Appoints Frank Rotmann VP & Head of European Operations

TORONTO, May 26, 2015 /PRNewswire/ – Merus Labs International Inc. (“Merus” or the “Company”) [TSX: MSL, NASDAQ: MSLI]  is pleased to announce the appointment of Frank Rotmann as Vice President and Head of European Operations, effective today. Based in Zurich, Switzerland, Mr. Rotmann has over 20 years of experience in the pharmaceutical industry. Most recently, he held the position […]

Read More »

Another Top Sanofi Exec Resigns, As Purging of Old Guard Continues

The purging of the old guard installed by former chief exec Chris Viehbacher continued at French drugmaker Sanofi (SNY) Monday, when the firm’s global head for prostate cancer drug Jevtana, Zhen Su, left to find work outside the company. The company did not issue a release on Su’s departure but the press learned about it […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom